期刊文献+

EN1调节UTROPHIN表达机制

The regulation of UTROPHIN expression by EN1
下载PDF
导出
摘要 为了探讨人类UTROPHIN蛋白表达上调的可能因素,文章利用P-match软件预测人类UTROPHIN基因启动子区域可能的调控元件,应用CHIP和EMSA实验加以验证,并利用RNA干扰和荧光定量PCR的方法分析人类EN1转录因子调节UTROPHIN表达的作用机制。经P-match软件预测,UTROPHIN基因启动子区域有2个转录因子EN1的可能结合位点,经CHIP和EMSA实验证实位点2是真正结合位点。通过RNA干扰实验,发现在HeLa细胞中EN1基因沉默后,可使UTROPHIN mRNA水平上调。以UTROPHIN蛋白为靶点可能为DMD(Duchenne muscular dystrophy)基因治疗提供一种新的策略。 To investigate possible factors up-regulating the expression of UTROPHtN, potential regulatory elements in the promoter of the human UTROPH1,N was predicted by P-match software and verified by EMSA and CHIP. The mechanism of EN1 regulation of the human UTROPH1N expression was evaluated by RNA interference and real-time PCR analyses. Two potential EN1 binding sites in UTROPHIN promoter region were predicted by P-Match software but only the second site was verified to interact directly with EN1 by EMSA and CHIP. The results from RNA interference and real-time PCR showed that the mRNA level of UTROPHIN increased in HeLa cells after EN1 was knockdowned by siRNA. It indicated that ENI might be a negative regulatory factor for UTROPH1N. Our study suggested that UTROPHIN might be a new target for DMD therapy.
出处 《遗传》 CAS CSCD 北大核心 2011年第4期347-352,共6页 Hereditas(Beijing)
基金 国家十一五攻关课题项目(编号:2006BAI05A08)资助
关键词 UTROPHIN蛋白 EN1转录因子 RNA干扰 荧光定量PCR UTROPHIN EN 1 RNA interfence Real-time PCR
  • 相关文献

参考文献25

  • 1Popplewell LJ,Trollet C,Dickson G,Graham IR.Design of phosphorodiamidate morpholino oligomers (PMOs) for the induction of exon skipping of the human DAM gene.Mol 71er,2009,17(3):554-561.
  • 2Aartsma-Rus A,Fokkema I,Verschuuren J,Ginjaar I,van Deutekom J,van Ommen GJ,den Dunnen JT.Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.Hum Mutat,2009,30(3):293-299.
  • 3Wang B,Li J,Fu FH,Xiao X.Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.J Orthop Res,2008,27(4):421-426.
  • 4Salvatori F,Cantale V,Breveglieri Q Zuccato C,Finotti A,Bianchi N,Borgatti M,Feriotto Q Destro F,Canella A,Breda L,Rivella S,Gambari R.Development of K562 cell clones expressing O-globin mRNA carrying the P039 thalassemia mutation for the screening of correctors of stop codon mutations.Biotechnol Appl Biochem,2009,54(1):41-52.
  • 5Cullen MJ,Walsh J,Nicholson LVB.Immunogold localization of the 43-kDa dystroglycan at the plasma membrane in control and dystrophic human muscle.Acta Neuropathol,1994,87(4):349-354.
  • 6Ambrosio F,Ferrari RJ,Fitzgerald GK,CarvellQBoninger ML,Huard J.Functional overloading of dystrophic mice enhances muscle-derived stem cell contribution to muscle contractile capacity.Arch Phys Med Rehabil,2009,90(1):66-73.
  • 7Mueller GM,ODay T,Watchko JF,Ontell M.Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.Hum Gene Ther,2002,13(9):1081-1090.
  • 8Bachrach E,Perez AL,Choi YH,Illigens BMW,Jun SJ,del Nido P,McGowan FX,Li S,Flint A,Chamberlain J,Kunkel LM.Muscle engraftment of myogenic progenitor cells following intraarterial transplantation.Muscle Nerve,2006,34(1):44-52.
  • 9Parker MH,Kuhr C,Tapscott SJ,Storb R.Hernatopoictic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs.Mol Ther,2008,16(7):1340-1346.
  • 10Hirst RC,McCullagh KJ,Davies KE.Utrophin upregulation in Duchenne muscular dystrophy.Acta Myol,2005,24(3):209-216.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部